Your browser doesn't support javascript.
loading
Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity.
Xu, Haifeng C; Grusdat, Melanie; Pandyra, Aleksandra A; Polz, Robin; Huang, Jun; Sharma, Piyush; Deenen, René; Köhrer, Karl; Rahbar, Ramtin; Diefenbach, Andreas; Gibbert, Kathrin; Löhning, Max; Höcker, Lena; Waibler, Zoe; Häussinger, Dieter; Mak, Tak W; Ohashi, Pamela S; Lang, Karl S; Lang, Philipp A.
Afiliación
  • Xu HC; Department of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich-Heine-University Düsseldorf, Universitätsstrasse 1, 40225 Düsseldorf, Germany; Institute of Immunology, Medical Faculty, University of Duisburg-Essen, Hufelandstrasse 55, Essen 45147, Germany.
  • Grusdat M; Department of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich-Heine-University Düsseldorf, Universitätsstrasse 1, 40225 Düsseldorf, Germany.
  • Pandyra AA; Institute of Immunology, Medical Faculty, University of Duisburg-Essen, Hufelandstrasse 55, Essen 45147, Germany.
  • Polz R; Department of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich-Heine-University Düsseldorf, Universitätsstrasse 1, 40225 Düsseldorf, Germany.
  • Huang J; Department of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich-Heine-University Düsseldorf, Universitätsstrasse 1, 40225 Düsseldorf, Germany.
  • Sharma P; Institute of Immunology, Medical Faculty, University of Duisburg-Essen, Hufelandstrasse 55, Essen 45147, Germany.
  • Deenen R; Biological and Medical Research Center (BMFZ), Cluster of Excellence on Plant Sciences (CEPLAS), Heinrich-Heine-University, Moorenstrasse 5, Düsseldorf D-40225, Germany.
  • Köhrer K; Biological and Medical Research Center (BMFZ), Cluster of Excellence on Plant Sciences (CEPLAS), Heinrich-Heine-University, Moorenstrasse 5, Düsseldorf D-40225, Germany.
  • Rahbar R; Campell Family Institute for Breast Cancer Research, Princess Margaret Cancer Center, University Health Network (UHN), 620 University Avenue, Toronto, Ontario M5G 2C1, Canada.
  • Diefenbach A; Institute of Medical Microbiology and Hygiene, University of Mainz Medical Center, Obere Zahlbacher Strasse 67, 55131 Mainz, Germany.
  • Gibbert K; Institute of Virology, University Hospital of Essen, University of Duisburg-Essen, Essen 45147, Germany.
  • Löhning M; Experimental Immunology, Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, 10117 Berlin, Germany; German Rheumatism Research Center (DRFZ), a Leibniz Institute, 10117 Berlin, Germany.
  • Höcker L; Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany.
  • Waibler Z; Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany.
  • Häussinger D; Department of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich-Heine-University Düsseldorf, Universitätsstrasse 1, 40225 Düsseldorf, Germany.
  • Mak TW; Campell Family Institute for Breast Cancer Research, Princess Margaret Cancer Center, University Health Network (UHN), 620 University Avenue, Toronto, Ontario M5G 2C1, Canada.
  • Ohashi PS; Campell Family Institute for Breast Cancer Research, Princess Margaret Cancer Center, University Health Network (UHN), 620 University Avenue, Toronto, Ontario M5G 2C1, Canada.
  • Lang KS; Institute of Immunology, Medical Faculty, University of Duisburg-Essen, Hufelandstrasse 55, Essen 45147, Germany.
  • Lang PA; Department of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich-Heine-University Düsseldorf, Universitätsstrasse 1, 40225 Düsseldorf, Germany. Electronic address: philipp.lang@med.uni-duesseldorf.de.
Immunity ; 40(6): 949-60, 2014 Jun 19.
Article en En | MEDLINE | ID: mdl-24909887
ABSTRACT
Despite development of new antiviral drugs, viral infections are still a major health problem. The most potent antiviral defense mechanism is the innate production of type I interferon (IFN-I), which not only limits virus replication but also promotes antiviralcell immunity through mechanisms, which remain insufficiently studied. Using the murine lymphocytic choriomeningitis virus model system, we show here that IFN-I signaling on T cells prevented their rapid elimination in vivo. Microarray analyses uncovered that IFN-I triggered the expression of selected inhibitory NK-cell-receptor ligands. Consequently, T cell immunity of IFN-I receptor (IFNAR)-deficient T cells could be restored by NK cell depletion or in NK-cell-deficient hosts (Nfil3(-/-)). The elimination of Ifnar1(-/-) T cells was dependent on NK-cell-mediated perforin expression. In summary, we identified IFN-I as a key player regulating the protection of T cells against regulatory NK cell function.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Interferón Tipo I / Linfocitos T CD8-positivos / Citotoxicidad Inmunológica / Receptor de Interferón alfa y beta / Coriomeningitis Linfocítica Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Interferón Tipo I / Linfocitos T CD8-positivos / Citotoxicidad Inmunológica / Receptor de Interferón alfa y beta / Coriomeningitis Linfocítica Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Alemania
...